3M Company vs Tilray Brands Inc — how do they compare? 3M Company trades at $160.35 (market cap $84.36B), while Tilray Brands Inc trades at $3.42 (market cap $530.54M). The key difference: 3M Company is far larger — about 159× Tilray Brands Inc's market cap, and 3M Company pays a 1.91% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold 3M Company for 169 Days and Tilray Brands Inc for 31 Days on average.
| MMM | TLRY | |
|---|---|---|
Market Cap | $84.36B | $530.54M |
Volume | 2,325,301 | 9,099,075 |
Sector | Industrials | Health |
52-Week High | $183.79 | $21.00 |
52-Week Low | $141.10 | $3.57 |
Typical Hold Time | 169 Days | 31 Days |
Enterprise Value | $93.58B | $684.46M |
Dividend Yield | 1.91% | — |
Signals from Pluang's Aura AI — not financial advice
3M (MMM) trades at $162.12, down 0.93% on the day, with a bearish technical signal and support near $158. The company reported strong Q2 2026 earnings, beating estimates with 5.4% organic growth and a 24.9% adjusted operating margin. Revenue for 2025 was $24.95B with net income of $3.25B, though margins have compressed from prior years. Analysts are mixed with a consensus price target of $191, representing potential upside, but high debt and weak consumer sales pose challenges.
The outlook for MMM is cautiously optimistic amid a genuine turnaround narrative. Investment opportunities include continued operational execution, shareholder returns via dividends and buybacks, and growth in industrial and electronics segments. Key risks involve persistent consumer segment weakness, litigation overhang from PFAS, and macroeconomic pressures affecting demand. The stock's valuation remains elevated with a P/E of 29.06, requiring sustained earnings growth to justify further gains.
TLRY trades at $3.465, down 6.73% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows weak technical momentum with oversold RSI readings but faces fundamental challenges including consecutive quarterly earnings misses, negative profit margins, and declining revenue growth. Recent news highlights the company's struggles with profitability despite record annual revenue, with shares down over 50% year-to-date as investors question the cannabis company's path to sustainable growth.
TLRY presents a high-risk opportunity with significant downside protection from its low P/B ratio of 0.33, but requires substantial operational improvement to justify investment. The bullish case hinges on potential marijuana reform catalysts and BrewDog integration progress, while risks include ongoing losses, competitive pressures, and execution challenges in a volatile regulatory environment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →